Browse studies

Find your next paid study

76 recruiting studies matching your filters

A US-Prospective, Registry-Based, Observational, Exposure Cohort Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population

This observational (enrollment into the registry while the pregnancy is ongoing) study is being conducted to compare the frequency of major congenital malforma…

Pregnancy RelatedAtopic Dermatitis

Estimated

~$10 – $1,050

Incyte CorporationNCT06259669

Phase 1

Clinical Evaluation of the Skin Microbiome and the Efficacy of an Over-The-Counter (OTC) Drug for Atopic Dermatitis

This is a research study. The over-the-counter (OTC) drug for atopic dermatitis being tested is not approved as a treatment for the participants' atopic dermat…

Atopic Dermatitis (AD)

Estimated

~$10 – $8,750

Good Molecules, LLCNCT07146971

Phase 4

Ethnic Differences in Mechanisms of Action of Dupilumab

Previous research has shown that Asian and African Americans are more likely to develop atopic dermatitis (AD) than their Caucasian counterparts. However, limi…

Atopic Dermatitis

Estimated

~$10 – $6,250

University of MichiganNCT05268107

A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

To collect, preserve, and/or distribute annotated biospecimens and associated medical data to institutionally approved, investigator-directed biomedical resear…

Estimated

~$10 – $1,050

Sanguine BiosciencesNCT05635266

Phase 3

A Phase 3, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study to Demonstrate Efficacy and Safety of DFL24498 Eye Drop Solution in Adult Participants With Atopic Keratoconjunctivitis (AKC)

This is a phase 3, multicenter, randomized, double-masked, parallel-group, vehicle-controlled study to evaluate the safety and efficacy of DFL24498 compared wi…

Atopic Keratoconjunctivitis

Estimated

~$10 – $7,500

Dompé Farmaceutici S.p.ANCT07395232

Phase 4

Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis

Single center, prospective, Open label study of sleep, pruritus and circadian function pre/post 12-weeks of dupilumab treatment in children 6-17 years old

Atopic DermatitisSleep Disturbance

Estimated

~$10 – $6,250

Northwestern UniversityNCT05042258

Phase 4

A Phase IV, Non-randomized, Open-label Multinational Trial to Assess the Mechanism of Action for Lebrikizumab in Moderate-to-severe Atopic Dermatitis

This research is studying a drug already approved for the treatment of atopic dermatitis (AD). This research collects health-related information and blood and …

Atopic Dermatitis

Estimated

~$10 – $7,500

Johann E Gudjonsson MD PhDNCT06906497

Phase 1

A Multi-part, FiH Study in Healthy Participants and Participants With Atopic Dermatitis (AD) to Assess the Safety, Tolerability, Pharmacokinetics (PK) of Single & Multiple Ascending Doses and Selected Dose of SYX-5219 (AD Participants).

The purpose of this study is to evaluate the study drug, SYX-5219, in a multi-part First-in-Human (FiH) study to be conducted in healthy volunteers and partici…

Moderate to Severe Atopic Dermatitis

Estimated

~$10 – $8,750

Sitryx Therapeutics LtdNCT07558668

Peripheral Blood, Urine and Skin Sample Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research

This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future researc…

Cutaneous T-cell LymphomaSezary SyndromeMycosis Fungoides+2 more

Estimated

~$10 – $750

University of PittsburghNCT00177268

Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT

The goal of this observational study is to learn about exposure to tralokinumab during pregnancy, as well as atopic dermatitis (AD) during pregnancy. The main…

Atopic DermatitisEczema

Estimated

~$10 – $750

University of California, San DiegoNCT05938478

Phase 2

A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Moderate to Severe Atopic Dermatitis (SIERRA1)

The main purpose of this study is to see how well different doses of soquelitinib work in participants with atopic dermatitis (AD) as compared to a placebo (pi…

Atopic DermatitisAtopic Dermatitis EczemaEczema+1 more

Estimated

~$10 – $8,750

Corvus Pharmaceuticals, Inc.NCT07441395

Registry for Systemic Eczema Treatments

The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) w…

Atopic Dermatitis

Estimated

~$10 – $750

Johns Hopkins UniversityNCT06136767